Sanofi Consumer public shareholders get open offer

As on date, Opella Healthcare owns controlling stake of 60.37% in Sanofi Consumer Healthcare India (SCHIL). On October 21, 2024, Sanofi and Clayton, Dubilier & Rice, LLC (CD&R, the manager of the Clayton Dubilier & Rice private equity funds) have announced that they have entered into exclusive negotiations whereby CD&R Group has agreed to acquire … Read more

Chinese scientists reverse type 1 diabetes with cell transplant

Chinese scientists claimed to have cured a chronic type-1 diabetes patient using cell transplants in what was stated to be the first such case in the world. The patient, a 25-year-old woman who had the chronic condition for over a decade, was able to naturally regulate her blood sugar some two and half months after … Read more

Alkem exploring JB Chem. Torrent pauses.

As per the news reports, Alkem is now exploring a potential buyout of J B Chemicals & Pharmaceuticals (JB). Torrent that was the speculated front runner for JB has paused talks due to the valuation differences. EQT, a Swedish investment major has also been said to give the acquisition a pass due to the valuation … Read more

Mankind Pharma acquires Bharat Serums

Mankind Pharma (MPL) is acquiring 100% of Bharat Serums (BSV) from the private equity major, Advent. BSV has a niche portfolio offering in Women’s Health, encompassing the entire lifecycle – from fertility to post-pregnancy. Deal is agreed at an Enterprise Valuation (EV) of Rs 13,630 cr translating to 28x of FY24 EBITDA. For comparison MPL’s … Read more

Medicine that can increase your longevity. Know about the anti-aging drug.

The discovery of an innovative drug represents a significant breakthrough in the field of anti-aging research. The newly discovered drug aims to inhibit a protein associated with aging, perhaps prolonging life and enhancing general health. Rats included in the experiments had a notable 25% longer lifespan and several other health benefits from the medication. The … Read more

Dr Reddy’s acquires Nicotine Replacement Therapy Brands

The Company has entered into a definitive agreement with British Consumer Healthcare player Haleon plc and its associate companies (Haleon) to acquire their consumer healthcare brands in the Nicotine Replacement Therapy (NRT) category, outside the United States. The acquisition has been done through Dr. Reddy’s Laboratories SA, Switzerland, a wholly owned subsidiary of the Company. … Read more